Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
After golf on WRAL: Man dead, woman injured after a shooting in Durham. Why residents say it's part of a larger spike in crime this year
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Senti Biosciences, Inc. - Common Stock
(NQ:
SNTI
)
2.890
+0.210 (+7.84%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
114,075
Open
2.770
Bid (Size)
2.750 (2)
Ask (Size)
2.890 (12)
Prev. Close
2.680
Today's Range
2.650 - 2.980
52wk Range
1.520 - 8.479
Shares Outstanding
2,752,774
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SNTI Stock Earnings: Senti Biosciences Reported Results for Q2 2024
August 13, 2024
Senti Biosciences just reported results for the second quarter of 2024.
Via
InvestorPlace
Senti Bio Announces Reverse Stock Split
July 16, 2024
Shares expected to begin trading on split-adjusted basis on July 18, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Performance
YTD
-56.28%
-56.28%
1 Month
+28.44%
+28.44%
3 Month
-10.47%
-10.47%
6 Month
-32.63%
-32.63%
1 Year
-53.61%
-53.61%
More News
Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 02, 2024
Via
InvestorPlace
SNTI Stock Earnings: Senti Biosciences Reported Results for Q1 2024
May 09, 2024
Via
InvestorPlace
Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks
July 02, 2024
Via
MarketBeat
Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening?
July 01, 2024
Via
Benzinga
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
July 01, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Why Is Beyond Air (XAIR) Stock Down 22% Today?
June 25, 2024
Via
InvestorPlace
Why Is Faraday Future (FFIE) Stock Down 27% Today?
June 25, 2024
Via
InvestorPlace
Why Is Senti Biosciences (SNTI) Stock Up 32% Today?
June 25, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 25, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
June 07, 2024
Via
Benzinga
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
May 13, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights
May 09, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)
April 30, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
SNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023
March 21, 2024
Via
InvestorPlace
Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
March 21, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 22, 2024
Via
Benzinga
Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program
January 05, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 25, 2023
Via
Benzinga
Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today?
December 22, 2023
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 22, 2023
Via
Benzinga
Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
December 22, 2023
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.